Sgrùdaidhean clionaigeach COPD ann an Alabama
Tha 21 sgrùdaidhean airson COPD a’ lorg phàirtichean aig làraichean ann an Alabama.
Bailtean ann an Alabama
Teacsa sgrùdaidh oifigeil (Beurla)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06961214A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
- Pulmonary Associates - Mobile- Site Number : 8400151, Mobile
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07190222A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 2
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A’ fastadhÌre 4
Aoisean 40 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06878261A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
A’ fastadhÌre 2/3
Aoisean 35 gu 80 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 50 gu 99 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
A’ fastadhÌre 3
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
A’ fastadh
Aoisean 22 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 30 gu 55 · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
A’ fastadh
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 28 Gibl 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
A’ fastadh
Aoisean 40 gu 84 · Gach gnè · Air ùrachadh 24 Gibl 2026 · NCT06891755PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Faoi 2026 · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 4
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 10 Samh 2025 · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
A’ fastadh
Aoisean 30 agus nas sine · Gach gnè · Air ùrachadh 6 Gearr 2025 · NCT05204888Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.